Regional Hospital of Agboville, Southern Cote d'Ivoire Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04410406
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Regional Hospital of Agboville, Southern Cote d'Ivoire

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Elephantiasis (Phase 3)

Elephantiasis, Filarial (Phase 3)

Filariasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4